PharmaTimes: News RSS
- CR UK forms £30m partnership with EU cancer charities
- Setback for Pharming’s bid to expand use of Ruconest
- EU green light for new Humira biosimilar
- Astellas’ kidney disease drug shows promise in PhIII
- Addex joins UK drug and brain research initiative
- Norgine buys rights to sell Shield’s iron deficiency therapy
- NICE rejects Novartis’ CAR-T Kymriah for adult lymphoma
- AI drug discovery platform gets £1m innovation boost
- The number of children being vaccinated in England falls again
- Almirall steps into psoriasis market with Ilumetri approval
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish
Leave a Reply
Want to join the discussion?Feel free to contribute!